Recent News

• 06.01.2026 - Minerva Neurosciences Establishes Scientific Advisory Board to Advance Development of Roluperidone and Future Pipeline Programs
• 05.18.2026 - Minerva Neurosciences to Participate in the 2026 Jefferies Global Healthcare Conference
• 04.02.2026 - Minerva Announces Leadership Transition

Recent Filings

• 05.27.2026 - 424B5 Prospectus [Rule 424(b)(5)]
• 05.27.2026 - 8-K Current report
• 05.15.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 05.15.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.05.2026 - 8-K Current report
• 05.05.2026 - EX-99.1 EX-99.1
• 05.05.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.23.2026 - DEF 14A Other definitive proxy statements
• 04.23.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.23.2026 - ARS Annual Report to Security Holders